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Abstract
Understanding the non-sensory components of the pain experience is crucial to
developing effective treatments for pain conditions. Chronic pain is associated
with increased incidence of anxio-depressive disorders, and patients often
report feelings of vulnerability which can decrease quality of life. In animal
models of pain, observation of behaviours such as thigmotaxis can be used to
detect such affective disturbances by exploiting the influence of nociceptive
stimuli on the innate behavioural conflict between exploration of a novel space
and predator avoidance behaviour. This study investigates whether acute and
repeated bladder inflammation in adult female Wistar rats increases
thigmotactic behaviour in the open field paradigm, and aims to determine
whether this correlates with activation in the central amygdala, as measured by
c-Fos immunoreactivity. Additionally, up-regulation of inflammatory mediators
in the urinary bladder was measured using RT-qPCR array featuring 92
transcripts to examine how local mediators change under experimental
conditions. We found acute but not repeated turpentine inflammation of the
bladder increased thigmotactic behaviour (decreased frequency of entry to the
inner zone) in the open field paradigm, a result that was also observed in the
catheter-only instrumentation group. Decreases in locomotor activity were also
observed in both models in turpentine and instrumentation groups. No
differences were observed in c-Fos activation, although a general increased in
activation along the rostro-caudal axis was seen. Inflammatory mediator
up-regulation was greatest following acute inflammation, with CCL12, CCL7,
and IL-1β significantly up-regulated in both conditions when compared to naïve
tissue. These results suggest that acute catheterisation, with or without
turpentine inflammation, induces affective alterations detectable in the open
field paradigm accompanied by up-regulation of multiple inflammatory
mediators.
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1. Introduction
Pain is a complex experience, dependent on the interplay between 
sensory aspects and centrally-mediated affective, motivational, 
cognitive, and behavioural elements. The current translational diffi-
culties in developing effective pain relief are associated in part with 
a pre-clinical focus on positive sensory signs, whereas the clinical 
burden of chronic pain comes largely from negative behavioural 
responses, such as avoiding behaviours perceived as exacerbating, 
and a general decrease in quality of life as a result of unpredict-
able spontaneous pain (Hummel et al., 2008; Suskind et al., 2013). 
This study uses an animal model to increase our understanding of 
the non-sensory components of pain by investigating whether acute 
and repeated visceral inflammation influence behaviour, if altera-
tions are associated with activational changes in central brain areas 
implicated in generation of affective behavioural responses, and 
investigate the local changes in cytokine levels twenty-four hours 
after inflammation.
Visceral pain affects 16–25% of the general population (Collett, 
2013), and is experienced by virtually all at some point, if only 
transiently. Despite this, visceral pain is inherently difficult to 
study in animal models, due to sparse innervation and referred 
pain complicating precise location of origin. This is reflected in 
the literature. A PubMed search conducted on the 22nd June 2014 
(search terms: (pain) AND (neuropathic) vs. (pain) AND (visceral)) 
revealed 12,938 results for pain with a neuropathic element, com-
pared to 5035 for pain with a visceral component. Of these, 510 
neuropathic studies were conducted in vivo, compared to only 40 
for visceral (additional search term: AND (in vivo)). None of these 
in vivo visceral pain publications involved the open field paradigm 
(additional search paradigm: AND (open field)), which was one of 
the key reasons for this study. We chose the turpentine model of 
visceral inflammation due to its simplicity of induction and dem-
onstrated phenotype of viscero-visceral hyper-reflexia and referred 
hyperalgesia (Jaggar et al., 1999), that is reversible with analgesics 
(Farquhar-Smith & Rice, 2001; Jaggar et al., 1998; Rice, 1995).
To detect negative behavioural responses in animals, complex 
behavioural outcomes are commonly used. Thigmotaxis is a behav-
iour characterised by a preference for movement along a surface 
(i.e. “wall-hugging”), which shows an inverse relationship with 
exploration of novel areas in rats. It is hypothesised as related to 
risk assessment and predator avoidance, with the presence of spon-
taneous or ongoing pain decreasing potentially risky behaviours, 
such as exploration. The open field paradigm is capable of detecting 
these subtle behavioural differences in experimental models of pain 
with varying aetiologies including antiretroviral therapy-induced 
neuropathy (Huang et al., 2013; Wallace et al., 2007; Wallace et al., 
2008), chemotherapy-induced neuropathy (Barzegar-Fallah et al., 
2014), spinal nerve transection (Blackbeard et al., 2012), spinal 
nerve ligation (Ewan & Martin 2014; Kontinen et al., 1999; Suzuki 
et al., 2007), chronic constriction injury (Grégoire et al., 2012), and 
post-traumatic peripheral nerve trauma (Medico et al., 2004).
Pain acts on multiple levels within the nervous system: sensory 
signals from the periphery are received centrally and interpreted 
in relation to previous experience and current circumstances to 
produce a behavioural response. The different subdivisions of the 
amygdala receive sensory input from areas such as the thalamus 
and spinal cord (capsulo-lateral portion of the central amygdala, via 
the lateral and basolateral amygdalae), and provides output via the 
medial nucleus of the central amygdala to the pre-frontal cortex and 
hypothalamus. This pattern of connectivity suggests involvement in 
the assessment and generation of emotional associations that form 
an integral part of the pain experience (Neugebauer et al., 2009). 
Studies have shown pain-associated increases in amygdala activ-
ity both clinically and pre-clinically in pancreatitis (Frøkjær et al., 
2011), cluster headache (Seifert et al., 2011), back pain, arthritis 
(Baliki et al., 2008), fibromyalgia (Harris et al., 2009), and men-
strual pain (Tu et al., 2010). In this study, we look at c-Fos immu-
noreactivity (a marker of persistent neural activation; Barth, 2007) 
in the amygdala with respect to open field activity, considering 
whether the presence of acute or persistent visceral inflammation 
influences c-Fos expression.
Cytokines and associated inflammatory mediators are up-regulated 
in pain conditions with an inflammatory component (Calvo et al., 
2012; Cheppudira et al., 2009; Girard et al., 2011; Johansson et al., 
2003; Nowak et al., 2012; Quan-Xin et al., 2012; Skurlova et al., 
2010; Zhang et al., 2013). In particular, Dawes and co-workers 
demonstrated commonality between cytokines up-regulated fol-
lowing UVB-irradiation in clinical and pre-clinical models, show-
ing the pro-inflammatory cytokine CXCL5 is up-regulated and 
capable of producing hypersensitivity in otherwise naïve rats 
(Dawes et al., 2011). In this study, we hope to show the profile 
of inflammatory mediators up-regulated following bladder inflam-
mation and investigate whether this profile changes with repeated 
inflammation.
This study aims to investigate the acute and medium-term effects 
of visceral inflammation on thigmotactic behaviour, correlating 
differences in behaviour with both central activation (c-Fos immu-
noreactivity in the amygdala), and peripheral levels of inflamma-
tory cytokines to further understand the behavioural implications of 
visceral inflammation.
Editorial note:
In this article, Morland et al. describe a blind analysis of the open 
field behaviour of rats under experimental and control conditions, 
and have included the blinded video data files (see Dataset). 
Blind analyses can be useful in removing a potential source of 
bias that could affect the interpretation of results.
We are encouraging interested researchers to conduct new 
analyses or reanalyses (e.g. replication attempts) on this data. To 
ensure the integrity of the blinded data, the unblinding lists will 
only be available upon request from F1000Research (research@
f1000.com). Investigators who wish to publish the results of their 
analyses in F1000Research will be provided with the unblinding 
lists shortly after submission of their initial draft manuscript.
Although we hope researchers will perform the analyses before 
requesting these lists, all requests will be honoured. The 
corresponding author (AR) is interested to gauge the usage of 
the unblinding lists and encourages requesters to cc him in when 
requesting them. For more details about this initiative, please 
email F1000Research or the corresponding author.
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2. Materials and methods
2.1 Ethical statement
All animal experiments conformed to British Home Office Regu-
lations (Animals (Scientific Procedures) Act 1986 Amendment 
Regulations 2012 (SI 2012/3039) and were performed under 
the authority of United Kingdom Home Office Project Licence 
70/7162, adhering to the International Association for the Study of 
Pain (IASP) guidelines for in vivo research (Zimmermann, 1983; 
and http://www.iasp-pain.org). Experiments were designed accord-
ing to Good Laboratory Practice standards (Macleod et al., 2009) 
and reported in accordance with the ARRIVE Guidelines (Kilkenny 
et al., 2010; Rice et al., 2013). Table 1 shows the major domains of 
good laboratory practice followed.
2.2 Experimental animals
Female Wistar rats (Charles River, UK, RRID:RGD_737929), 
weighing 180–200 g on arrival, were housed in groups of 3–4 in 
individually ventilated cages with free access to food (RM1 (P), 
Special Diet Services, UK) and tap water. Animals were main-
tained under a 12 hour light cycle (07:00–19:00) in temperature 
and humidity-controlled conditions (25°C, 30%, both ± 5). Cages 
were cleaned weekly on a Tuesday (p.m.), and housed in a room 
containing mice and rats of both sexes. Animals were habituated to 
the holding room for a minimum 48 hours after delivery from the 
main campus facilities.
2.3 Study design
Sample size calculations used data from studies looking at the effect 
of neuropathic injury (spinal nerve transection) on frequency of 
inner zone entry in the open field (Morland et al., 2015 manuscript 
in preparation). Using a power (1-β) of 0.08 and alpha (α) value of 
0.05, a sample size of 8 was calculated as sufficient to detect altera-
tions in thigmotaxis.
There were three experimental groups: naïve, instrumentation 
(anaesthesia with catheterization and instillation of 0.5ml 100% 
olive oil), and turpentine (anaesthesia with catheterization, and 
inhalation anesthetic instillation of 0.5ml 50% turpentine). Full 
details of group sizes and exclusions are given in Figure 1. Female 
animals were selected for ease of catheterization.
All behavioural experiments were conducted during the light phase 
(09:00–18:00) in a dedicated behavioural laboratory, with surgi-
cal procedures carried out in a separate but adjacent surgical room. 
In vivo studies were conducted in batches of 2–3 animals per group 
(n=6–9/batch) due to capacity and protocol constraints. Each ani-
mal was treated as a single experimental unit, with immunohisto-
chemical analysis conducted using average values from a number of 
sequential sections from a single animal, as summarized in Table 2.
2.4 Model induction
Under isoflurane anaesthesia, (1.5–3% in 2 L/min O2), bladder 
inflammation was induced as described by McMahon & Abel 
(1987). Briefly, a transurethral catheter (⌀ 1.02mm; Portex, UK) 
was introduced into the bladder, and position verified by applying 
gentle abdominal pressure to empty the bladder, before instillation 
of 0.5 ml olive oil or turpentine (50% in olive oil). The instillation 
was maintained under anaesthesia for 2 hours before removal of 
the catheter. The animal was allowed to recover in a separate area 
before returning to the home cage.
Table 1. Major Domains of Good Laboratory Practice (after Macleod et al., 2009).
Characteristic Description of procedures
Sample size calculation
Group size was determined by sample size estimation for each experiment by SigmaStat 
software, version 3.5 (ANOVA sample size, desired power = 0.8, α = 0.05). Effect sizes 
for estimation were derived from previous studies in our group. 
Inclusion and exclusion 
criteria
Animals which died prior to/during model induction were excluded from further study. 
There were no exclusion criteria for the open field study; animals were excluded from 
c-Fos analysis if >90min elapsed between open field and perfusion, or if sections were 
badly damaged.
Randomization Animals were randomised to model group (naïve, VC, TC) by cage using a pseudorandom ABCBCACAB labelling system.
Allocation concealment
The person creating the model (i.e. instillation of turpentine or olive oil) was theoretically 
unaware of the allocation to treatment group, but due to the pungent odour of turpentine, 
this was difficult to maintain. Procedures were still followed. This was achieved by the 
blinding procedure described below, as well as masking cage labels or turning around 
the cages before each behavioural assessment session.
Reporting of animals 
excluded from analysis All animals excluded are reported in Figure 1.
Blinded measurement, 
assessment, and analysis 
of outcome
Codes were assigned to different treatments by an independent person and kept in a 
sealed envelope. The codes were not broken until the analysis had been completed. 
The experimenter was blinded to the experimental group to which an animal was 
randomized. In addition, open field videos were renamed by an independent person 
before analysing, and immunohistochemistry sections were identified by animal not 
group code.
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Based on the above protocol, a model of persistent bladder inflam-
mation was developed, involving three instillations, each one week 
apart. For both studies, surgery was conducted during the light 
phase and timed to ensure exactly 24 hours between instillation and 
exposure to the open field.
2.5 Cytokine activation
Tissue from whole bladders snap frozen during the saline phase 
of perfusion was used for RNA extraction. Briefly, samples were 
homogenized and total RNA obtained using a “hybrid” method of 
phenol extraction (Trizol, Invitrogen, USA) and column purifica-
tion (RNeasy, Qiagen, USA). All samples were deoxyribonuclease 
(DNase, Qiagen, USA) treated to avoid genomic contamination. 
Purity and integrity confirmed with an RNA 6000 Nano Chip 
(Agilent, USA). Complementary DNA (cDNA) was synthe-
sized from RNA using a SuperScript II reverse transcriptase kit 
(Invitrogen, USA).
Custom-made Taqman array cards (as described by Dawes et al., 
2011), featuring four sets of 92 different primer pairs, and four 
house-keeping genes: glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), 18S ribosomal protein, β-actin, and β2-microtubulin. 
Inflammatory mediators were categorized into cytokines, chemok-
ines, growth factors, enzymes, and ‘other’ (Table S1). Each cDNA 
sample was diluted with PCR-grade water and added in a 1:1 ratio 
to Taqman Universal master mix to produce a final concentration 
of 1 ng/µl cDNA. Samples were loaded into the appropriate ports 
(1 µl/well) according to manufacturer guidelines. Cards were placed 
into a 7900HT Fast Real-Time PCR system (Applied Biosystems, 
USA), and subjected to 40 cycles of amplification. Transcript 
expression was measured with the ΔΔC
t
 (cycling time) method 
normalised to the geometric mean of the four housekeeping genes 
using the R package NormqPCR (https://r-forge.r-project.org/
projects/qpcr/). Relative changes in transcript levels are presented 
Table 2. Average number of sections analysed per 
animal during immunohistochemical analysis.
Mean Min Max
Acute
Naïve 5.10 4 7
Instrumentation 4.88 4 7
Turpentine 4.46 3 6
Repeated
Naïve 2.87 1 5
Instrumentation 3.90 2 6
Turpentine 3.83 1 7
Figure 1. Experimental design for both acute and repeated models. The arrows on the right show the total number of animals used, with 
exclusions at each timepoint and final group sizes indicated in the central and right of the diagram respectively. Animals were lost during 
surgery due to complications associated with anaesthesia, and excluded from immunohistochemical analysis if hemispheric differentiation 
was not possible.
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as fold change (FC). When transcript numbers were undetermined 
for a given detector in <50% of samples, the average C
t
 value was 
calculated with the remaining data values. If transcript numbers 
were undetermined in >50% of transcripts for a given sample, a 
default C
t
 of 38 was assigned. If these conditions coincided, no FC 
value was calculated. Difference in gene expression were detected 
using the significance analysis of microarray (SAM) technique, 
involving calculation of false discovery rates (FDR), represented as 
a q statistic (Lin et al., 2008; Xiao et al., 2002).
2.6 Thigmotaxis in the open field
Humidity and temperature were maintained at 25°C and 30% 
humidity respectively. Light levels outside the isolation chamber 
during open field paradigms ranged from 70–300 lux. As rodents 
have a greater auditory range than humans, ultrasonic sound record-
ings were taken using a Mini-3 Bat Detector (Ultra Sound Advice, 
UK) to determine the background levels of high frequency sound 
generated by equipment. Fluorescent lighting and computer equip-
ment emitted signals within the 20–50 kHz range - this equipment 
was switched on for the duration of each experiment and animals 
were allowed to acclimatise to the testing room for 30 min prior to 
testing.
Thigmotaxis. The open field paradigm was used to assess thigmo-
taxis. The open field arena (black, 100 cm2) was enclosed in an 
isolation chamber (115 × 115 × 255 cm) to minimise environmental 
interference. Light levels within the open field were set at 12 lux 
(measured in the centre of the arena). Animals were introduced into 
the near corner of the arena, facing the centre of the arena, and 
allowed to explore for 15 min. The arena was cleaned with 0.02% 
Distel (formerly Trigene, Tristel Solutions Ltd., UK) between tri-
als. Behaviour was captured by high sensitivity camera (VCB 3372; 
Sanyo, Japan), and analysed using Ethovision XT 10.1 (Tracksys, 
UK (for Noldus, the Netherlands), RRID:rid_000100). The primary 
pre-determined outcome measure was frequency of entry into a 
virtual central zone (40 cm2). Secondary outcome measures were 
duration in the central zone, and rearing. Total distance travelled 
was used as a measure of general locomotor activity. Rearing was 
defined as both forelimbs elevated, either against a wall, or free-
standing, and measured by a trained observer watching at 4 × play-
back speed.
2.7 Amygdala activation
Histological studies. To capture peak c-Fos activation in response 
to the open field, fixation perfusion took place within 90–120min 
of open field exposure. Bladders were extracted and snap frozen in 
LN2 during the saline phase of perfusion fixation.
Animals were humanely killed with pentobarbital and transcar-
dially perfused with 0.9% heparinized saline followed by 4% 
paraformaldehyde. The brain was removed and post-fixed in 4% 
paraformaldehyde for 6 hours and cryo-protected in 30% sucrose 
for at least 3 days prior to sectioning (50 µm) on a freezing micro-
tome (model no. HM450, Thermo Scientific, USA). Sections were 
washed in phosphate buffered saline (PBS; 1(NaH2PO4.2H2O): 
9(Na2HPO4.12H2O):7(NaCl) in dH2O), quenched with 0.03% H2O2 
(Sigma-Aldrich,
 
UK), washed again in PBS, blocked for one hour 
in 5% normal goat serum (NGS, Millipore, UK; PBS with 0.3% 
TX (Triton X-100, BDH, UK)), before incubation overnight at 4°C 
with 1:20,000 polyclonal rabbit IgG anti-c-Fos (Santa Cruz Bio-
technology Cat# sc-52 RRID:AB_2106783; 0.3% PBS-TX, 2% 
NGS). The following day, sections were washed in PBS and incu-
bated for two hours at room temperature (20°C) with 1:250 Biotin- 
SP-conjugated Affinipure goat anti-rabbit IgG (F(ab’)2 fragment 
specific; Jackson ImmunoResearch, USA, Cat# 111-036-006 RRID:
AB_2313586; 0.3% PBS-TX, 2% NGS). Staining was visualised 
using a Vectastain ABC kit (avidin-biotin-peroxidase complex, 
VectorLabs, UK) and DAB (3, 3′-Diaminobenzidine) with nickel 
salt intensification (VectorLabs, UK). Sections were mounted, 
counterstained with toluidine blue to enhance cyto-architecture, 
and cover-slipped using DePex mounting media (VWR, UK) prior 
to image capture.
Image quantification. The bregma position of each mounted section 
was determined with reference to Paxinos & Watson (6th Edition, 
2007), and only those between -1.44mm and -3.36mm (range of the 
central amygdala) were captured using a Leica DM R light micro-
scope (Leica Microsystems, Germany). Image analysis was con-
ducted using Photoshop CS5 (Adobe, USA), and the mean number 
of positively stained cells per mm2 calculated for each subdivision 
of the central amygdala (medial, lateral, and capsular), with later-
alization and rostro-caudal axis position noted. A positively stained 
cell was defined as having a clearly defined dark rounded nucleus 
(blue/black) - sections without c-Fos positive cells in areas out-with 
the central amygdala were excluded. Image analysis was conducted 
blind, using individual animal identifiers rather than group codes 
until completion of analysis.
2.8 Statistical analysis
Thigmotaxis was analysed using 1-way ANOVA, with Kruskal-
Wallis utilised for data that was not normally distributed. c-Fos 
data was analysed using 1-, 2-, and 3-way ANOVA taking account 
of hemispheric, sub-nuclear, and rostro-caudal designations of the 
central amygdala. Where overall ANOVA detected significant dif-
ferences, multiple comparisons procedures were used - Holm-Sidak 
for normally distributed data, and Dunn’s multiple comparison for 
non-parametric tests. Correlations were assessed using Pearson 
correlation coefficients. Inflammatory mediator analysis was con-
ducted using Significance Analysis of Microarrays (SAM), and the 
false discovery method (FDR), which take into account dependence 
between transcripts and uses non-parametric techniques. Signifi-
cance was taken as q=0%.
Summary statistics are expressed as mean (standard deviation; SD) 
when data was normally distributed, or median (interquartile range; 
IQR) when data failed normality testing. Significance was taken at 
p<0.05.
All statistical tests were performed, sample sizes calculated, and 
appropriate graphs generated using OriginPro v9.1 (OriginLab, 
USA) and SigmaPlot v10 (Systat Software Inc., USA; RRID:
SciRes_000184).
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3. Results
Cytokine q-RT-PCR, c-Fos immunoreactivity and open field 
behaviour data in rats following bladder inflammation
6 Data Files
http://dx.doi.org/10.6084/m9.figshare.1394861
Exclusions
See Figure 1 for a summary of exclusions and group sizes used. 
Bladder inflammation as a model of visceral inflammation was 
generally well tolerated; the main cause of mortality was surgical 
complications and related anaesthesia. In the repeated model, all 
deaths occurred during/following the final inflammation session. 
Following recovery from anaesthesia and return to the home cage, 
animals were alert and outwardly indistinguishable.
3.1 Inflammatory mediator mRNA levels
3.1.1 Acute bladder inflammation. A total of 81/92 cytokine tran-
scripts were analysed for magnitude and significance of transcript 
up-regulation following acute bladder inflammation. 11 markers 
(CCL1, CCL28, CTLA-8, CXCL17, IFNγ, IL-2, IL-3, IL-4, IL-9, 
IL-13, IL-27) were excluded from the acute inflammation model 
due to high cycle time (>38), indicative of low levels or issues in 
detection. The top ten up-regulated transcripts are shown in Table 3. 
Figure 1 shows the rank FC for all markers analysed. Significance 
analysis of microarrays (SAM) was used to identify 25 mRNAs 
that were significantly different in the turpentine group compared 
to naive (FC >1.5, Δ = 1.61, FDR=0%). Of these, 13 were classified 
as chemokines, 9 as cytokines, 2 as enzymes, 2 as growth factors, 
and 1 as ‘other’, as seen in Table 4.
3.1.2 Repeated bladder inflammation. A total of 75/92 cytokine 
transcripts were analysed for magnitude and significance of 
transcript up-regulation following repeated bladder inflammation. 
16 markers (CCL1, CCL3, CCL25, CCL26, CCL28, CXCL3, 
IL-2, IL-3, IL-4, IL-9, IL-13, IL-19, IL-20, IL-27, C5, and IFNγ) 
were excluded from the repeated inflammation model due to high 
cycle time (>38 overall mean). One housekeeping gene (18s) 
was excluded as it was significantly up regulated. FC was there-
fore calculated normalized to the remaining housekeeping genes 
(HPRT, ACTB, and GAPDH). Figure 2 shows fold change rank 
for all cytokines analysed. The top 10 mRNA transcripts up- 
regulated following repeated bladder inflammation with turpentine 
are shown in Table 3. Using SAM, we identified 4 mRNAs that were 
significantly different in turpentine compared to naive (FC >1.5, 
Δ = 1.61, FDR=0%). Of these, 3 were classified as chemokines 
(CCL7, CCL12, and CXCL17, and 1 as cytokine (IL-1β), as seen in 
Table 4.
3.1.3 Comparison of inflammatory mediator up-regulation fol-
lowing acute and repeated bladder inflammation. From a possi-
ble list of 92 transcripts, 73 were detected in both models. Table 5 
shows the mean rank, standard deviation, and super rank value 
(SRV) for each transcript examined. Of these IL-1β was signifi-
cantly up regulated in both (FDR q=0%). Two other chemokines, 
CCL7 (acute: 272.74 FC; repeated: 7.15 FC), and CCL12 (acute: 
17.96 FC; repeated: 7.15 FC), were also significantly up-regulated 
in both models (FDR q=0%).
3.2 Open field behaviour
3.2.1 Acute bladder inflammation. Thigmotactic behaviour was 
observed in animals from both instrumentation and turpentine 
groups. Animals in both these groups entered the inner zone less 
frequently compared to naïve (1-way ANOVA, p=0.009). Turpen-
tine animals entered the inner zone 8.6 times (SD 5.84, p=0.025), 
whereas the instrumentation group averaged 6.3 entries (SD 3.68, 
p=0.0035), both significant compared to the naïve value of 13.9 
entries (SD 6.86) as shown in Figure 3A.
Table 3. Top 10 up-regulated transcripts in bladder tissue from turpentine group, ranked by mRNA fold change 
normalised to naive values. Data presented as mean fold change (95% confidence interval), n=3–4 animals/group.
Acute Bladder Inflammation Repeated Bladder Inflammation
Rank Gene Fold Change 95% Confidence Interval Gene Fold Change
95% Confidence 
Interval
1 NOS2 159110.28 -127366.6–445587.2 CCL12 169.65 67.05–272.25
2 PROK2 11060.01 -12741.5–34861.5 CTLA-8 75.098 -56.21–206.4
3 CXCL2 3679.32 -4618.0–11976.7 CXCL17 71.2 -22.64–165.03
4 CCL3 2541.99 -1417.4–6501.3 CXCL11 53.27 -71.05–177.6
5 IL-1α 1827.32 -2717.6–6372.2 NOS2 14.2 -9.46–37.87
6 IL-1β 403.78 -328.2–1135.7 BDNF 11.9 -2.06–25.86
7 CSF3 350.52 -269.9–971.0 CXCL2 9.94 -9.78–29.65
8 CXCL3 254.33 -131.8–640.5 PROK2 9.12 -10.24–28.49
9 IL-10 222.75 -399.6–845.1 IL-21 8.88 -17.20–34.96
10 IL-6 153.21 -42.8–349.3 IL-1β 8.63 4.62–12.65
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Table 4. Significance analysis of qRT-PCR array (SAM) results for acute and repeated bladder inflammation. 
Significant fold difference in acute modela , repeated modelb , or bothc ; Significance level, FDR q=0% denoted by bold text.
Acute Repeated
FC Score (d) q-value(%) FC Score (d) q-value (%)
Chemokines
CCL2a 43.47 4.63 0.00 3.36 1.43 8.44
CCL3a 1656.98 8.89 0.00 transcript excluded 
CCL4a 95.66 2.55 0.00 6.74 1.13 8.44
CCL6a 14.34 2.52 0.00 3.98 1.90 5.52
CCL7c 17.96 2.37 0.00 5.44 3.47 0.00
CCL12c 149.46 3.70 0.00 120.42 8.28 0.00
CCL20a 66.21 3.69 0.00 9.71 1.40 8.44
CXCL1a 218.46 2.71 0.00 3.42 1.21 8.44
CXCL2a 9412.93 5.23 0.00 5.63 1.22 8.44
CXCL3a 75.99 2.61 0.00 transcript excluded 
CXCL6a 106.35 4.74 0.00 5.24 1.17 8.44
CXCL17b transcript excluded 34.53 4.15 0.00
XCL1a 0.01 -4.93 0.00 2.38 0.45 15.95
Cytokines
CSF2a 91.78 5.87 0.00 2.20 0.57 15.95
CSF3a 1355.83 4.75 0.00 5.23 0.87 10.67
IL-1αa 2857.26 4.63 0.00 5.46 1.60 5.52
IL-1βc 272.74 5.88 0.00 7.15 2.68 0.00
IL-6a 522.18 4.78 0.00 4.57 1.11 8.44
IL-10a 334.63 3.67 0.00 2.83 0.48 15.95
IL-24a 233.58 4.22 0.00 0.11 -0.98 21.98
IL-35 / Ebi3a 45.77 2.46 0.00 3.15 1.10 8.44
Tnfa 20.44 3.20 0.00 2.42 1.13 8.44
Enzymes
Nos2a 81737.07 11.43 0.00 13.87 1.98 5.52
COX-2 / Ptgs2a 8.42 2.66 0.00 0.96 -0.07 21.98
Growth Factors
Artna 0.37 -2.46 2.26 0.39 -1.61 20.25
Erega 140.20 3.15 0.00 24.38 1.91 5.52
Other PROK2a 4443.04 7.25 0.00 8.52 1.34 8.44
Figure 2. Ranked mean fold change of inflammatory cytokine mRNA transcripts 24 hours after acute (n=4) and repeated bladder 
inflammation (n=3), as compared to naive data, showing the increased up-regulation present following acute inflammation as 
compared with repeated inflammation. Following significance of microarray analysis, only inflammatory mediators showing up-regulation 
were significant (q=0%).
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Table 5. Super rank values (SRV), consolidating 
cytokine up-regulation following acute and 
repeated bladder inflammation with turpentine.
SRV Gene Mean Rank SD
1 Nos2 3 1.41
2 CXCL2 5 0.71
2 Prok2 5 7.07
4 IL-1β 8 2.83
5 CCL12 9.5 4.24
6 IL-1α 13.5 7.07
7 Bdnf 15 8.49
8 C3 18.5 4.95
9 IL-35 / Ebi3 19 4.95
10 Ereg 19.5 10.6
Duration in the inner zone was not significantly different between 
groups (Kruskal-Wallis 1-way ANOVA, p=0.192). The median time 
spent in the inner zone was 11.52s (6.68–29.20), 6.80s (2.88–12.96), 
and 8.64s (2.56–14.32) for naïve, instrumentation, and turpentine 
groups respectively (Figure 3C). Rearing behaviour was not signifi-
cantly different between groups (1-way ANOVA, p=0.112), with 
mean rear counts of 51.31 (14.96), 43.20 (14.08), and 37.23 (19.70) 
for naïve, instrumentation, and turpentine groups respectively 
(Figure 3E).
Distance travelled was reduced in both instrumentation (7411.62cm 
IQR 6584.73–7970.77) and turpentine (6744.29cm IQR 3843.16–
8192.87) groups when compared to naïve (Dunn’s post-hoc test 
p<0.05, 8771.06cm IQR 7860.85–10,188.78; Figure 3G).
3.2.2 Repeated bladder inflammation. No significant effect of 
group was observed on inner zone frequency (p=0.185) or dura-
tion (p=0.288), with naïve entering the inner zone an average of 
11.5 (6.22) times with a duration of 13.76s (9.6–23.7), instrumenta-
tion averaging 8.7 (5.7) entries with a median duration of 14.48s 
(6.6–27.2), and turpentine entering the inner zone 7.25 (6.0) times, 
with a median duration of 6.96s (1.76–16.72) (Figure 3B and D). 
No difference was seen in rearing activity (p=0.638), with mean 
rear counts of 56.9 (13.9), 48.6 (7.7), and 52.22 (21.67) for naïve, 
instrumentation, and turpentine groups respectively (Figure 3F).
A decrease in distance travelled was seen in both instrumentation 
(p=0.015, 6797.29 cm SD 1637.10) and turpentine (p=0.00026, 
5974.04cm SD 2039.67) groups compared to naïve (8432.59cm SD 
953.15; overall 1-way ANOVA p<0.001, Figure 3H).
3.3 c-Fos immunoreactivity in the central amygdala in 
response to open field exposure
3.3.1 Acute bladder inflammation. Higher levels of c-Fos immu-
noreactivity were seen in the left hemisphere (p=0.0031), localised 
to the CeM (p=0.032). No other differences in c-Fos immunore-
activity were observed in the central amygdala, and there was no 
effect of group, as shown in Figure 4, with full c-Fos density data in 
Table 6.
3.3.2 Repeated bladder inflammation. The CeC showed higher lev-
els of f-cos immunoreactivity compared to the CeM (p=0.00485).
A rostro-caudal gradient was seen with significantly higher levels 
of activation observed in the caudal regions (p=0.016). Significant 
differences were also observed within levels, with the rostral CeL 
(p=0.013) and caudal CeC (p=0.001) showing higher levels when 
compared to the CeM. c-Fos immunoreactivity in the CeM exhib-
ited a rostro-caudal gradient, with the rostral region containing 
fewer positive cells compared to the intermediate (p<0.001) and 
caudal regions (p=0.002). There was no effect of group on c-Fos 
immunoreactivity (Figure 4 and Table 6).
3.4 Correlations
3.4.1 Acute bladder inflammation. Overall, there was a positive 
correlation between rearing activity and c-Fos immunoreactivity in 
the rostral CeC (Pearson’s ρ=0.44, p=0.01).
Looking at correlations within experimental groups, the naïve 
group showed the highest levels of correlation, with rearing activity 
positively correlated with CeC (Overall, right hemisphere, and ros-
tral level; ρ=0.73–80, p<0.05) and CeM (caudal; ρ=0.72, p=0.03). 
Distance travelled was also positively correlated with caudal c-Fos 
immunoreactivity in the left central amygdala (ρ=0.8, p=0.02).
In the instrumentation group, there was a positive correlation 
between duration in the inner zone and c-Fos immunoreactivity 
in the intermediate CeL (ρ=0.76, p=0.05). No correlations were 
observed in the turpentine group.
See Table 7 and Table S2 for full details of all correlations.
3.4.2 Repeated bladder inflammation. Overall, there were correla-
tions between frequency, duration, and rearing and c-Fos immu-
noreactivity in the central amygdala. Frequency was positively 
correlated with CeL immunoreactivity in the left hemisphere 
(ρ=0.35, p=0.03), and CeM immunoreactivity in the right hemi-
sphere (ρ=0.35, p=0.04) and caudal level (ρ=0.39, p=0.02). Duration 
in the inner zone was positively correlated with rostral CeL (ρ=0.33, 
p=0.05), caudal CeM (ρ=0.37, p=0.02), and c-Fos immunore-
activity in all intermediate divisions except the right hemisphere 
(ρ=0.34–0.41, p<0.05). Rearing was negatively correlated with 
CeM (overall, left, right, and rostral; ρ=-0.43- -0.67, p<0.05), right 
overall (ρ=-0.41, p=0.05), right CeL (ρ=-0.46, p=0.02), and caudal 
CeC (ρ=-0.52, p=0.01).
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Figure 3. Open field behaviour 24hrs after acute (A,C,E,G; n=9–13) or repeated (B,D,F,H; 10–16) bladder inflammation. A/E - Frequency 
of entry to the inner zone, B/F - duration in the inner zone (s), C/G - rearing frequency, D/H - total distance travelled (cm).
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Figure 4. c-Fos immunoreactivity in the central amygdala in response to open field exposure 24hrs after acute (A,C; n=8–13) or repeated 
(D,F; n=7–15) bladder inflammation. A/D - Global CeA (central amygdala) c-Fos immunoreactivity, B/E - right CeA, C/F - left CeA.
Within the naïve group, there were positive correlations between 
distance travelled and rostral c-Fos immunoreactivity (overall, 
left, and CeL; ρ=0.58–0.67, p<0.02). Frequency in the inner zone 
was positively correlated with caudal (overall, CeM; ρ=0.52–0.61, 
p<0.05) and rostral CeL c-Fos immunoreactivity (ρ=0.58, p=0.02). 
Duration in the inner zone was positively correlated with CeC 
(left, intermediate; ρ=0.59, p=0.02), CeL (left, rostral; 0.53–0.62, 
p<0.04), caudal CeM (ρ=0.66, p=0.01), left hemisphere (over-
all, intermediate, caudal; ρ=0.52–0.56, p<0.05), and interme-
diate (ρ=0.53, p=0.04). No correlations were seen with rearing 
behaviour.
In the instrumentation group, distance travelled was positively 
correlated with left CeL (ρ=0.71, p=0.02), and rearing was nega-
tively correlated with left rostral c-Fos immunoreactivity (ρ=-0.93, 
p=0.02).
In the turpentine group, duration in the inner zone was correlated 
with intermediate CeM c-Fos immunoreactivity (ρ=0.64, p=0.02). 
Rearing behaviour was negatively correlated with c-Fos immu-
noreactivity in the CeM (overall, right, caudal; ρ=-0.71- -0.90, 
p<0.03), and in the right hemisphere (rostral, CeL; ρ=-0.76- -0.78, 
p<0.02).
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Table 6. c-Fos immunoreactivity in the central amygdala in response to open 
field exposure 24hrs after bladder inflammation. Data presented as mean (95% 
confidence interval). Acute: n=8–13; Repeated: n=7–15. Data shown as mean (SD).
Acute Repeated
(n) Mean SD (n) Mean SD
Global
Naïve 9 14.90 13.68 15 80.07 67.84
Instrumentation 8 15.78 10.87 12 109.35 106.23
Turpentine 13 17.07 19.84 10 96.32 80.11
CeM
Naïve 9 12.46 11.56 15 38.57 40.36
Instrumentation 8 16.43 15.03 11 69.85 71.48
Turpentine 13 11.94 15.28 10 63.82 61.90
CeL
Naïve 9 18.37 17.14 15 102.51 118.49
Instrumentation 8 18.77 17.53 12 128.13 127.28
Turpentine 13 24.95 35.61 9 106.05 105.16
CeC
Naïve 9 15.39 14.41 15 85.11 63.44
Instrumentation 8 15.23 12.13 12 125.96 146.11
Turpentine 13 14.76 15.78 10 110.56 120.35
Rostral
Naïve 9 13.24 10.04 15 35.68 38.87
Instrumentation 8 17.71 19.50 12 62.51 62.65
Turpentine 13 9.45 10.72 10 55.13 74.87
rCeM
Naïve 9 10.90 12.31 15 21.03 36.25
Instrumentation 8 20.55 30.80 12 28.87 56.66
Turpentine 11 6.34 9.29 10 24.07 58.06
rCeL
Naïve 9 10.28 11.44 15 43.34 64.35
Instrumentation 7 12.30 9.29 12 42.54 62.00
Turpentine 13 9.93 11.28 10 28.58 65.83
rCeC
Naïve 9 15.25 12.31 15 36.05 36.41
Instrumentation 8 9.79 11.35 12 45.95 53.22
Turpentine 13 9.28 12.69 10 75.68 123.36
Intermediate
Naïve 9 15.29 16.00 15 76.56 102.99
Instrumentation 8 13.05 11.92 12 59.38 62.55
Turpentine 13 18.86 27.82 10 75.83 69.03
iCeM
Naïve 9 11.97 9.85 15 25.62 35.61
Instrumentation 7 11.13 9.02 12 40.17 45.61
Turpentine 13 6.68 14.15 10 58.73 72.41
iCeL
Naïve 9 20.63 31.44 15 109.55 198.56
Instrumentation 6 29.79 45.97 12 50.20 76.14
Turpentine 11 39.75 68.04 10 82.66 66.41
iCeC
Naïve 9 16.64 20.33 15 56.19 87.06
Instrumentation 8 9.06 10.30 12 50.95 61.50
Turpentine 12 16.44 20.75 10 85.96 87.11
Caudal
Naïve 9 16.18 17.90 15 107.27 136.63
Instrumentation 8 16.56 22.56 12 120.59 140.43
Turpentine 13 22.90 29.71 10 114.58 102.95
cCeM
Naïve 9 16.32 21.38 15 69.99 139.71
Instrumentation 6 18.82 19.43 12 46.16 103.93
Turpentine 13 23.79 43.28 10 68.25 71.35
cCeL
Naïve 4 14.39 18.66 15 34.54 41.57
Instrumentation 7 27.68 42.25 12 189.22 283.47
Turpentine 9 22.45 34.54 10 143.61 51.92
cCeC
Naïve 4 9.90 17.47 15 44.86 66.93
Instrumentation 7 12.17 19.04 12 138.74 156.49
Turpentine 10 31.07 32.48 10 136.03 81.07
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See Table 7 and Table S2 for full details of all correlations.
4. Discussion
Both acute and repeated bladder inflammation up-regulate inflam-
matory mediator expression, most notably IL-1β, CCL-7, and 
CCL-12. The fold change was higher in the acute model compared 
to the repeated, suggestive of a habituation effect when an animal 
is repeatedly exposed to an inflammatory stimulus. Thigmotactic 
alterations were observed in both instrumentation and turpentine 
groups following acute but not repeated bladder inflammation, 
although reductions in locomotor activity were observed in both 
models. Investigations into amygdalar c-Fos immunoreactivity fol-
lowing bladder inflammation were inconclusive.
Numerous studies investigating cytokine expression profiles across 
experimental models of inflammatory pain show results similar to 
those reported here. IL-6, IL-10, and TNFα are highly expressed 
in normal bladder tissue (Pokrywczynska et al., 2013), and have 
pro-inflammatory actions (de Oliveira et al., 2011). Additionally, in 
a study examining cytokine expression following UVB irradiation, 
five markers also seen in our model of acute bladder inflammation 
were up-regulated: CCL-4, CCL-7, IL-1β, IL-24, and iNos/Nos2, 
of which IL-1β and CCL-7 were also seen in our repeated model 
(Dawes et al., 2011). In an acute model of pelvic pain (experi-
mental prostatitis) there was increased expression of both CCL7 
and CCL12, and seven other chemokines also seen in acute blad-
der inflammation (CCL2, CCL3, CCL4, CCL6, CXCL2, CXCL3, 
and XCL1), suggesting commonality in inflammatory mediators 
up-regulated in pelvic inflammatory models (Quick et al., 2012). 
Considering the effects of systemic cytokines on behaviour, periph-
eral IL-1β is associated with decreased activity in the open field, 
whether administered exogenously (Campbell et al., 2010; Song 
et al., 2005), or endogenously up-regulated in response to inflam-
matory stimuli such as lipopolysaccharide (LPS) (Swiergiel & 
Dunn, 2007) and intra-plantar carrageenan (Wen et al., 2014). In a 
study combining peripheral and systemic effects of cytokines with 
behaviour and c-Fos immunoreactivity in the amygdala, IL-1β, 
TNFα, and IL-6 reduced activity, with TNFα and IL-1β also associ-
ated with increased c-Fos immunoreactivity in the central amygdala 
(Skelly et al., 2013).
Open field behaviour was reduced in both turpentine and instru-
mentation groups following acute and repeated bladder inflamma-
tion. Distance travelled was decreased in both instrumentation and 
turpentine groups following acute and repeated bladder inflamma-
tion. Exaggerated thigmotactic behaviour (reduced frequency and 
duration of inner zone visits) was observed only in the acute model, 
but in both turpentine and instrumentation groups, suggesting cath-
eterisation and instillation of vehicle (olive oil) could be capable 
of creating an aversive state. Notably, a similar trend was also 
seen in the repeated, although this did not reach significance due 
to high levels of variation. Previous studies examining cyclophos-
phamide (CYP)-induced cystitis revealed mixed effects on behav-
iour: male mice showed reduced rearing activity but increased time 
active in the open field four hours after acute injection (Olivar & 
Laird, 1999), however a recent study found no difference distance 
travelled in the open field following CYP treatment in female rats 
(Coelho et al., 2014). Other models of visceral inflammation show 
similarly mixed effects: trinitrobenzenesulfonic acid (TNBS)-
induced acute pancreatitis increased immobility in male mice three 
weeks post-insult (Cattaruzza et al., 2013), but this effect was not 
seen in the cerulein-induced model of pancreatitis (Michalski et al., 
2007). Chronic iodoacetamide (IAA)-induced gastritis reduced 
inner zone activity in female but not male rats (Luo et al., 2013), 
whereas acute intra-colonic instillation of mustard oil is reported 
to either reduce open field locomotor activity (Maia et al., 2006), 
or have no effect (Leite et al., 2012). A similar model of persistent 
colonic inflammation (deoxycholic acid/DCA) also failed to detect 
differences in distance travelled in the open field (Traub et al., 2008). 
However, intra-plantar CFA has been shown to induce thigmotactic 
behaviour without reducing distance travelled in the open field, up 
to 30 days after the original insult, suggesting the effects of acute 
inflammation can persist (Parent et al., 2012). Our data supports the 
idea that inflammation is capable of changing behaviour twenty-
four hours after inflammation, but that this effect is not specific to 
introduction of an irritant into the bladder, and there is an element 
of habituation, as suggested by the reduced effects observed in the 
repeated model.
The presence of behavioural alteration in both surgical groups sug-
gests the instillation procedure in itself is enough to alter behav-
iour. The volume instilled (0.5ml) is within the physiological range, 
accounting for diurnal variation (Herrera & Meredith, 2010), sug-
gesting the pressure generated would be insufficient to initiate a 
noxious stretch response. Therefore, olive oil and/or catheterisation 
are capable of influencing open field behaviour. Anti-nociceptive 
effects of intra-peritoneal olive oil injection have been shown (Eidi 
et al., 2012), and there are numerous studies investigating its pur-
ported anti-inflammatory effects in relation to the Mediterranean 
diet (for review see Lucas et al., 2011), suggesting olive oil may 
have a protective rather than inflammatory effect. On the other 
hand, catheterisation is known as a risk factor for cystitis (Dayts, 
2014; Tenke et al., 2014) and pelvic pain (Nazarko, 2014), suggest-
ing further investigation is required into mechanisms involved in 
the behavioural alterations we saw in our instrumentation groups.
In the current study, we failed to detect an effect of instrumentation 
or turpentine on c-Fos immunoreactivity. Increased activity was 
seen in the lateral (CeL; rostral) and capsular (CeC; caudal) when 
compared with the medial central amygdala (CeM). The CeL and 
CeC often considered together as they both receive input from the 
spinal cord, and brainstem, as well as signals from higher regions 
such as the cortex, via the thalamus (Neugebauer et al., 2004). We 
noted significantly higher levels of activation in the caudal regions 
of the central amygdala, and although the biological significance 
of this is not known, it has been previously observed in a model of 
CYP-induced cystitis (Bon et al., 1998). No significant effects were 
seen in the acute model, suggesting the link between open field 
outcomes and central amygdala activation may be time-dependent, 
however the lack of robust correlations between behaviour and c-Fos 
immunoreactivity in this model could also be indicative of reduced 
involvement of the CeA in the inflammatory-mediated behavioural 
alterations we observed. Another factor to consider is the higher 
levels of immunoreactivity seen in the repeated model compared to 
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the acute model. This is observed across all experimental groups, 
suggesting an environmental effect associated with differences in 
the housing of the animals.
Other studies involving inflammatory models have shown associ-
ated increases in central amygdala activation: c-Fos immunoreac-
tivity in the central amygdala was increased 60 minutes after acute 
intra-peritoneal injection of the gastric hormone CCK (cholecysto-
kinin) (Rinaman, 2003), and intra-plantar formalin was associated 
with an increased c-Fos immunoreactivity detectable for up-to 2 
(Rouwette et al., 2011). However, our data is not directly com-
parable with these studies as the acute timescale considered was 
considerably shorter than the twenty-four hours we studied. Fur-
thermore, our experiment was designed to investigate whether 
recent visceral inflammation alters central amygdala activity in 
response to the open field, as opposed to c-Fos in response to 
noxious stimuli alone.
A study looking at blood flow and proliferation (cell number and 
volume) found these measures increased in the central amygdala 
following spared nerve injury, without a concomitant alteration 
in elevated plus maze or open field behaviour (Gonçalves et al., 
2008). Nonetheless, thigmotaxis has been observed in association 
with increased central amygdala activity in peripheral nerve trauma 
(Burke et al., 2013), and post-operative incisional models (Li et al., 
2010), emphasising the complexity of central amygdala involve-
ment the generation of thigmotactic behavioural alterations.
We found a significant negative correlations between CeM c-Fos 
immunoreactivity and rearing behaviour in the repeated turpentine 
group in particular, suggesting rearing behaviour may be suppressed 
by CeM activity, although we failed to detect significant alterations 
in rearing. c-Fos immunoreactivity in the CeM was generally lower 
than that seen in the CeL/C, as would be expected when consid-
ering the CeL and CeC are involved in modulation of incoming 
noxious signals, whereas the CeM is thought to be more involved 
in initiation of the behavioural response. Investigations into the 
direct effect of experimental pain states on amygdala activation 
have shown up-regulation in the central amygdala, (Dai et al., 1993; 
Hayashi et al., 2009; de Lange et al., 2005; Lehner et al., 2006; Rea 
et al., 2011; Rouwette et al., 2012; Yamashiro et al., 1998; Yang 
et al., 2010) but none have investigated differences between nuclear 
subdivisions.
High levels of variability were observed across all data sets, sug-
gesting innate behavioural variation. Numerous studies have shown 
evidence for a divergent response to stress, and typically note the 
presence of two behavioural phenotypes – those that have low activ-
ity and high neophobia (low activity/high “anxiety”), and those that 
show higher levels of activity, and low levels of neophobia (high 
activity/low “anxiety”) (Koolhaas, 2008; Koolhaas et al., 2010; 
Mällo et al., 2007; Kabbaj et al., 2000; Landgraf & Wigger, 2002). 
We noted the presence of distinctive behavioural phenotypes in all 
groups including naive, characterised by low or high thigmotaxis, 
and are developing techniques to investigate these differences fur-
ther – ideally, animals would be behaviourally phenotypes prior to 
inflammation in order to determine the effects of trait character-
istics on state responses. A previous study has shown differential 
c-Fos expression in animals with differing behavioural phenotypes, 
namely up-regulation of central c-Fos expression in low activity/
high “anxiety” rats (Salomé et al., 2004). However, although the 
rats used in our study were the same strain (Wistar, Charles River, 
UK), those in the Salome study were bred for high and low anx-
iogenic phenotype in the elevated plus maze (F12), which would 
likely magnify underlying neurochemical differences present in the 
original strain. Additionally, the duration of open field exposure 
was 30 minutes, as compared to the 15 minutes in our study, and 
it is likely that this would affect the c-Fos activation profile as the 
animal habituates to its environment.
To fully elucidate the c-Fos response to open field exposure, and 
determine whether the increase in caudal activation we observed 
has biological significance, further experiments comparing animals 
with and without exposure to the open field are required. Investigat-
ing cytokine profiles in more individuals would allow further corre-
lation between behavioural outcomes and physiological pathology, 
and could be particularly instructive in understanding the effect 
seen in the instrumentation groups. Studies have shown behavioural 
responses to systemic IL-1β are variable (Pertsov et al., 2009), and 
also that acute responses can vary with oestrus cycle in female rats 
(Avitsur et al., 1995), suggesting investigations taking this into 
account may increase the robustness of this study, although a lit-
erature survey conducted in 2014 found similar variability between 
male and female animals (Prendergast et al., 2014). Furthermore, 
there are potential refinements that could be applied to this model 
to facilitate testing behaviour at earlier time points, including 
reducing the duration of instillation and therefore anaesthesia 
required by using a more specific and/or potent irritant. Finally, 
testing of behavioural phenotype prior to treatment allocation 
would allow more detailed study of whether and how behavioural 
phenotype modulates responses to visceral inflammation.
In summary, bladder inflammation is associated with a robust up-
regulation of peripheral cytokines implicated in pain, inflammation, 
and behavioural depression, and acutely with increased thigmo-
taxis, not specific to inflammation. The data on neural correlates 
are inconclusive, but as increased variation in these outcomes is 
observed, further studies are required to elucidate mechanisms 
responsible.
Data availability
Figshare: Cytokine q-RT-PCR, c-Fos immunoreactivity and open 
field behaviour data in rats following bladder inflammation doi: 
10.6084/m9.figshare.1394861  (Morland et al., 2015).
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Table S1. Cytokine qRT-PCR Array Card Targets.
Chemokines Cytokines Growth Factors Enzymes
Complement 
System Other
Housekeeping 
Genes
CCL1 M- CSF1 Areg Alox5 C3 Aif1 18S
CCL2 GM- CSF2 Artn Alox15 C5 Edn1 Actb
CCL3 G- CSF3 Bdnf Lta4h PROK2 Gapdh
CCL4 Ifng Btc Nos2 Hprt1
CCL5 IL-1α Ereg Ptges
CCL6 IL-1β Fgf7 Ptgs2
CCL7 IL-2 Hbegf
CCL9 IL-3 Kitlg
CCL11 IL-4 Ngf
CCL12 IL-5 Nrg1
CCL17 IL-6 Nrg1 (exon j)
CCL19 IL-7
CCL20 IL-9
CCL21b IL-10
CCL22 IL-11
CCL24 IL-12a
CCL25 IL-12b
CCL26 IL-13
CCL27 IL-14 / Txlna
CCL28 IL-15
CX3CL1 IL-16
CXCL1 IL-17 / CTLA-8
CXCL2 IL-18
CXCL3 IL-19
CXCL4 / Pf4 IL-20
CXCL6 IL-21
CXCL7 / Ppbp IL-23a
CXCL9 IL-24
CXCL10 IL-27
CXCL12 IL-33
CXCL13 IL-35 / Ebi3
CXCL14 Lif
CXCL16 Mif
CXCL17 Tnf
XCL1
Supplementary materials
ARRIVE Checklist. Click here to access the file.
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In the manuscript entitled “Short-term effect of acute and repeated urinary bladder inflammation on
thigmotactic behaviour in the laboratory rat” authors report their observations on the effects of acute and
repeated bladder inflammation in open-field associated behavioral parameters like locomotion,
thigmotaxis and rearings. In addition, the expression of inflammatory mediators in the bladder was
analyzed by RT-qPCR and c-fos expression was quantified in the amygdala. Authors observed that
turpentine driven inflammation in the bladder resulted in the up-regulation of inflammatory mediators
particularly following acute challenge; these observations were not controlled for the effect of
catheterization. Turpentine inflammation was associated with a decreased number of entries in the central
area of the open-field area; in this case authors controlled for the effect of catheterization alone and
observed that this group displayed a similar phenotype. Again, acutely challenged subjects were more
affected. C-fos expression in the amygdala following open-field exposure was inconclusive.
The manuscript is well-written and is in many aspects exemplar, adhering to the best practices in data
reporting (sample size calculation, inclusion/exclusion criteria for experimental subjects, randomization,
among others). Also, authors made available an interesting set of raw data permitting reanalysis to
anyone interested. Finally, authors stress the importance of having alternative measures in pain models
that go beyond sensory testing.
  
There are however some aspects that need clarification:
Authors preformed an exhaustive characterization of inflammation-associated transcripts
expressed in the bladder; it is not clear what was the gain of this approach in the context presented
by the authors in the introduction to the study; after all the model involved trauma (associated with
the catheterization) and the injection of turpentine, therefore inflammation in the bladder was not an
unexpected outcome. On the contrary, I would see some advantages if authors would have treated
animals with anti-inflammatory drugs or, more importantly, if the strategy was applied in CNS
tissues (namely in the amygdala); indeed a number of studies have associated the up-regulation of
inflammatory mediators with anxiety-like behaviors.  
 
Instrumentation and turpentine animals present a robust decrease in the distance travelled in the
open-field most probably as a result of inflammation-driven sickness behavior. Because open-field
readouts depend on animal’s ability to move, other behavioral parameters can be indirectly
affected. Have authors controlled for this? Have other measures be taken like animals’ weight,
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affected. Have authors controlled for this? Have other measures be taken like animals’ weight,
grooming, body temperature, etc? These would be particularly important in the repeated model.
 
c-fos density values presented for naïve animals present an increase over 5 fold between acute
and repeated models (in the global analysis; similar increases can be found in the segmented
analysis); apart from open-field exposure naïve animals should by definition be equal. My concern
is that such effect can mask biologically relevant variations of c-fos expression (e.g. ceiling effect).
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
 19 May 2015Referee Report
doi:10.5256/f1000research.6710.r8597
 Nicholas Andrews
Department of Neurology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
This is very detailed description of an interesting study attempting to bring together behaviour, anatomy
and neurochemical responses. The methods are very clearly described. I have only a few minor points for
the authors to consider.
Introduction
The case is made for the amygdala in relation to pathways involved in pain relay but not made for
combining with open field. The open field arguably elicits thygmotaxis through a neophobic and spatial
effects which might relate more closely to the hippocampus. A little more in the introduction discussing the
known relationship between the amygdala and open field behaviour would be helpful to the reader and
place the choice of test in greater context.
Results
Can the reduction in frequency of entries into the centre be explained by a general reduction in motor
activity? If this is accounted for in an ANCOVA does the reduced time in the centre become more or less
pronounced?
Was velocity altered between the groups? Might also reflect wariness?
Discussion
Is it possible that the variation of responses in the open field is due to the lack of clear salient stimuli for
causing the thygmotaxis? A more discrete training stimulus as evident in conditioned fear-based
paradigms may give less variability. Have the authors considered using other such tests, especially in
light of the strong body of evidence relating conditioned fear to amygdala function?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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 Gordon Munro
Department of Pharmacology, NeuroSearch A/S, Ballerup, Denmark
The manuscript submitted by Morland has assessed whether rats with acute or more prolongedet al. 
bladder inflammation induced by turpentine oil exhibit thigmotactic behaviour as assessed in the open
field paradigm. In addition, regulation of inflammatory mediators within the bladder and c-Fos
immunoreactivity within the central amygdala was assessed.
 
The authors provide a clearly defined hypothesis which they address appropriately with a number of the
methodologies at hand. In the absence of a direct method to assess pain-like behaviour in the various
groups I like that the authors assessed inflammatory mediator profiles using a well established
methodology previously utilized in other experimental pain models (e.g. UV burn) where pain-like
behaviours were measured directly. The manuscript is well written. The data have been analysed using
appropriate statistical tests and the results are extensively described. Although the data ultimately reveal
that instrumentation rather than inflammation  can sufficiently induce thigmotactic behaviour thisper se
should not detract from the value of this work. Rather, the extensive description of study design,
powering, randomization, blinding, exclusions and availability of their data for the scrutiny of their peers
makes this work in many ways a first, and an extremely valuable addition to the field in my opinion. This
said I have a number of issues with some of the included work as described in more detail below.
 
Major points
The value of the current work would have been considerably enhanced if the experimental design
had included a separate arm in which vehicle treated rats were treated with an anxiolytic dose of
e.g. diazepam, or a motor impairing dose of an opiate like morphine with corresponding plasma
samples obtained for purposes of drug exposure. Despite the extensive detail provided within the
Methods section I find it extremely difficult to judge the sensitivity of their open field paradigm
without the availability of this kind of information.
 
The inclusion of the c-Fos data in the context of the current manuscript is to be blunt, both
confusing and distracting. This is not because the data are inconclusive in that noper se, 
differences in c-Fos immunoreactivity were noted between instrumentation or turpentine treated
groups. I would have expected that the authors might have seen a more robust pattern/magnitude
of c-Fos immunoreactivity if rats in these 2 groups had been sacrificed at 90 minutes after induction
of the procedure rather than the following day following open field performance. Whilst careful
consideration and extensive reporting of experimental design was provided in relation to
performing behavioural analysis, I just can’t see that the same is the case for the purposes of
assessing ‘Amygdala activation’. Incidentally, without knowing precisely the function and
phenotype of the c-Fos positive cells included in their analysis, I would suggest that this term is
misleading – I think the authors might be aware of this as indicated at the bottom of page 14. The
authors specify that sequential sections were obtained from each rat. I would presume that in a
number of cases depending upon the exact plane of the sections that the same positive neurones
were measured more than once. Accordingly, with section numbers ranging from 1-7 per rat as
indicated in Table 2 this must introduce some form of bias between treatments. This issue goes
against the grain of the rigorous experimental designs employed for purposes of behavioural
analyses As such, I would strongly recommend that the authors remove all c-Fos related method
and results from the manuscript. Alternatively, they could provide videocapture of all sections used
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and results from the manuscript. Alternatively, they could provide videocapture of all sections used
in their analyses and provide this for open review to see if others can replicate their finding
Minor points
When performing c-Fos immuno were all sections processed within the same experimental run? If
not, were assays blocked appropriately to contain representative samples from each of the
treatment groups?
 
Following on from the above, a generalized positive control group (with a background in
neuroendocrinology I would have included a group of rats treated with eg hypertonic saline and
measured c-Fos expression within specific hypothalamic nuclei such as the SON or PVN) would
have provided a general measure of assay sensitivity.
 
Can the authors comment on whether all rats were tested during similar stages of the oestrus
cycle? Does this matter?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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